✦ LIBER ✦

Placebo-controlled trial of lubiprostone for constipation associated with Parkinson disease

✍ Scribed by Ondo, W. G.; Kenney, C.; Sullivan, K.; Davidson, A.; Hunter, C.; Jahan, I.; McCombs, A.; Miller, A.; Zesiewicz, T. A.

Book ID: 111863251
Publisher: Lippincott Williams and Wilkins
Year: 2012
Tongue: English
Weight: 339 KB
Volume: 78
Category: Article
ISSN: 0028-3878
DOI: 10.1212/wnl.0b013e3182574f28

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical trial: lubiprostone in patients

Clinical trial: lubiprostone in patients with constipation-associated irritable bowel syndrome – results of two randomized, placebo-controlled studies

✍ D. A. DROSSMAN; W. D. CHEY; J. F. JOHANSON; R. FASS; C. SCOTT; R. PANAS; R. UENO 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 477 KB

Macrogol for the treatment of constipati

Macrogol for the treatment of constipation in Parkinson's disease. A randomized placebo-controlled study

✍ Roberta Zangaglia; Emilia Martignoni; Margaret Glorioso; Maria Ossola; Giulio Ri 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 2 views

## Abstract Chronic constipation is the most frequent symptom of autonomic system involvement in Parkinson's disease (PD). Quite often the symptom is severe and impairs patients' quality of life. The objective of this study is to determine the efficacy and safety of an isosmotic macrogol solution f

Clinical trial: phase 2 study of lubipro

Clinical trial: phase 2 study of lubiprostone for irritable bowel syndrome with constipation

✍ J. F. JOHANSON; D. A. DROSSMAN; R. PANAS; A. WAHLE; R. UENO 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 218 KB

Randomized controlled trial of memantine

Randomized controlled trial of memantine in dementia associated with Parkinson's disease

✍ Iracema Leroi; Ross Overshott; E. Jane Byrne; Emily Daniel; Alistair Burns 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 338 KB 👁 1 views

## Abstract The objective of this study is to investigate the safety and tolerability of memantine, a glutamatergic modulator, in patients suffering from dementia associated with Parkinson's disease (PDD), an increasingly common complication of PD. This was a 22‐week trial of 25 participants with a

Randomized placebo-controlled trial of d

Randomized placebo-controlled trial of donepezil in cognitive impairment in Parkinson's disease

✍ Iracema Leroi; Jason Brandt; Stephen G. Reich; Constantine G. Lyketsos; Stephen 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 1 views

## Abstract ## Objective To evaluate the efficacy and safety of donepezil, an acetylcholinesterase inhibitor, as a treatment for cognitive impairment and dementia in patients with Parkinson' s disease (PD). ## Methods Using a randomized, double‐blind, placebo‐controlled design, nine patients rec

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled trial of levetiracetam for dyskinesia in Parkinson's disease

✍ Kitty K. Wong; Jane E. Alty; Amanda G. Goy; Sanjay Raghav; David C. Reutens; Pet 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 565 KB

## Abstract ## Background: This randomized double blind, placebo‐controlled crossover study investigated the antidyskinetic effects of levetiracetam in Parkinson's disease. ## Methods: Sixteen participants with levodopa‐induced dyskinesia were enrolled. Hourly videotaped dyskinesia assessments s